eIF4AIII Activators
eIF4AIII, a vital component of the exon junction complex (EJC), is a linchpin in the intricate regulation of translation initiation. Traditionally scrutinized for its inhibitory functions, delving into the activation mechanisms of eIF4AIII becomes imperative to unravel the diverse roles it plays in cellular physiology. A curated exploration of chemicals reveals a spectrum of compounds with the potential to either directly or indirectly activate eIF4AIII, providing a more comprehensive understanding of its regulatory landscape. In the realm of nuanced regulation, one noteworthy activator is pateamine A, a natural product known to bind to eIF4AI and eIF4AII, both members of the eIF4A family. Despite its historical inhibitory characterization, the complex cellular response to pateamine A introduces a layer of intricacy, suggesting a dual role in both inhibition and activation contingent on the cellular context. Likewise, rocaglamide, a natural product, and CR-1, a synthetic compound, display inhibitory effects on eIF4AIII. However, the nuanced cellular responses hint at potential indirect activation or modulation, adding a layer of complexity to their interactions.
Shifting focus to indirect influences, compounds like mycophenolic acid and CX-5461 exert their impact on eIF4AIII by altering cellular processes upstream. This underscores the interconnectedness of translation initiation regulation and highlights how changes in these processes can indirectly influence eIF4AIII. Additionally, pladienolide B, by modulating alternative splicing, indirectly affects translation initiation. This indirect influence occurs through alterations in splicing patterns, further emphasizing the intricate connections within the regulatory network. In conclusion, the comprehensive examination of these chemicals reveals the nuanced regulatory network governing eIF4AIII. The identification of dual roles, indirect influences, and interconnected pathways underscores the complexity of eIF4AIII activation in cellular processes. This understanding is pivotal for advancing research in deciphering the intricate regulatory mechanisms of eIF4AIII in both health and disease.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Silvestrol | 697235-38-4 | sc-507504 | 1 mg | $920.00 | ||
Silvestrol is a natural product that binds to eIF4A, particularly eIF4AI, inhibiting its helicase activity. This leads to the modulation of translation initiation, affecting the expression of specific genes. | ||||||
Rocaglamide | 84573-16-0 | sc-203241 sc-203241A sc-203241B sc-203241C sc-203241D | 100 µg 1 mg 5 mg 10 mg 25 mg | $275.00 $474.00 $1639.00 $2497.00 $5344.00 | 4 | |
Rocaglamide is a natural product known for its inhibitory effects on eIF4A, directly binding to the protein and impeding its helicase activity. While traditionally categorized as an inhibitor, the complex cellular response to rocaglamide may involve compensatory mechanisms and feedback loops, potentially influencing eIF4AIII indirectly. | ||||||
N1-Guanyl-1,7-diaminoheptane (GC7) | 150333-69-0 | sc-396111 | 10 mg | $143.00 | 2 | |
N1-Guanyl-1,7-diaminoheptane is a synthetic compound known for its modulatory effects on translation initiation. While the specific interaction with eIF4AIII may not be well-defined, it influences cellular processes that indirectly impact eIF4AIII activity. The intricate nature of cellular responses to N1-guanyl-1,7-diaminoheptane necessitates a nuanced examination of its effects on eIF4AIII and the broader translation initiation machinery. | ||||||
Mycophenolic acid | 24280-93-1 | sc-200110 sc-200110A | 100 mg 500 mg | $69.00 $266.00 | 8 | |
Mycophenolic acid is a natural product with immunosuppressive properties, and it indirectly affects translation initiation. By inhibiting inosine monophosphate dehydrogenase (IMPDH), it reduces the cellular pool of guanine nucleotides, impacting translation initiation indirectly through alterations in mRNA cap structures. | ||||||
Pladienolide B | 445493-23-2 | sc-391691 sc-391691B sc-391691A sc-391691C sc-391691D sc-391691E | 0.5 mg 10 mg 20 mg 50 mg 100 mg 5 mg | $299.00 $5699.00 $11099.00 $25500.00 $66300.00 $2875.00 | 63 | |
Pladienolide B is a natural product that binds to the spliceosome and modulates alternative splicing, indirectly affecting translation initiation. Its impact on eIF4AIII may result from alterations in the splicing patterns of transcripts involved in translation regulation. | ||||||
CX-5461 | 1138549-36-6 | sc-507275 | 5 mg | $245.00 | ||
CX-5461 is a synthetic compound that targets RNA polymerase I, indirectly impacting translation initiation by modulating ribosomal RNA synthesis. While not a direct activator of eIF4AIII, its influence on translation initiation emphasizes the interconnectedness of cellular processes governing protein synthesis. | ||||||
Isoginkgetin | 548-19-6 | sc-507430 | 5 mg | $225.00 | ||
Isoginkgetin is a natural product with inhibitory effects on eIF4A, directly binding to the protein and impeding its helicase activity. While traditionally categorized as an inhibitor, the complex cellular response to isoginkgetin may involve compensatory mechanisms and feedback loops, potentially influencing eIF4AIII indirectly. | ||||||